BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruffner MA, Kennedy K, Cianferoni A. Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications. Expert Rev Clin Immunol 2019;15:83-95. [PMID: 30394139 DOI: 10.1080/1744666X.2019.1544893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ghezzi M, Pozzi E, Abbattista L, Lonoce L, Zuccotti GV, D'Auria E. Barrier Impairment and Type 2 Inflammation in Allergic Diseases: The Pediatric Perspective. Children (Basel) 2021;8:1165. [PMID: 34943362 DOI: 10.3390/children8121165] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Votto M, Marseglia GL, De Filippo M, Brambilla I, Caimmi SME, Licari A. Early Life Risk Factors in Pediatric EoE: Could We Prevent This Modern Disease? Front Pediatr 2020;8:263. [PMID: 32548083 DOI: 10.3389/fped.2020.00263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
3 Oliva S, Azouz NP, Stronati L, Rothenberg ME. Recent advances in potential targets for eosinophilic esophagitis treatments. Expert Rev Clin Immunol 2020;16:421-8. [PMID: 32163308 DOI: 10.1080/1744666X.2020.1742110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Harb H, Chatila TA. Mechanisms of Dupilumab. Clin Exp Allergy 2020;50:5-14. [PMID: 31505066 DOI: 10.1111/cea.13491] [Cited by in Crossref: 35] [Cited by in F6Publishing: 68] [Article Influence: 11.7] [Reference Citation Analysis]